- Home
- W vs KYMR Comparison
W vs KYMR Comparison
Compare W & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | W | KYMR |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 9.6B |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | W | KYMR |
|---|---|---|
| Price | $87.86 | $106.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 28 | 26 |
| Target Price | $105.82 | ★ $107.72 |
| AVG Volume (30 Days) | ★ 2.8M | 562.2K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $39,211,000.00 |
| Revenue This Year | $7.39 | $10.61 |
| Revenue Next Year | $6.00 | $8.17 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $55.60 | $36.88 |
| 52 Week High | $119.98 | $130.05 |
Technical Indicators
Market Signals| Indicator | W | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 50.46 | 46.15 |
| Support Level | $84.24 | $76.40 |
| Resistance Level | $95.82 | $120.37 |
| Average True Range (ATR) | 4.20 | 4.42 |
| MACD | -0.42 | -2.00 |
| Stochastic Oscillator | 46.55 | 3.37 |
Price Performance
Historical ComparisonAbout W Wayfair Inc.
Wayfair engages in e-commerce in the United States (88% of 2025 sales), Canada, the United Kingdom, and Ireland. It's also embarked on expansion into the brick-and-mortar landscape, with 13 stores (excluding outlets) between the AllModern, Birch Lane, Joss & Main, and Wayfair banners. At the end of 2025, the firm offered more than 40 million products from more than 20,000 suppliers under the brands Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold. Its offerings include furniture, everyday and seasonal decor, decorative accents, housewares, as well as advertising and logistics services. Wayfair was founded in 2002 and began trading publicly in 2014.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.